Cross Country Healthcare Inc (CCRN)
Who owns Cross Country Healthcare Inc (CCRN)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 91.9% of the shares are freely tradable; institutional investors hold 91.3%.
Ownership Structure
Largest Shareholders
Institutions
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| Boston Partners Global Investors, Inc | 8.21 | 2,545,584 | +221.5 | 03/31/2026 |
| BlackRock Inc | 8.09 | 2,507,042 | -0.6 | 03/31/2026 |
| Vanguard Group Inc | 6.14 | 1,904,150 | +4.5 | 12/31/2025 |
| Dimensional Fund Advisors, Inc. | 5.19 | 1,609,925 | -15.5 | 03/31/2026 |
| Vanguard Capital Management, LLC | 4.42 | 1,369,654 | +0.0 | 03/31/2026 |
| Sio Capital Management, LLC | 3.54 | 1,098,393 | +2.8 | 03/31/2026 |
| Quinn Opportunity Partners LLC | 3.31 | 1,025,620 | -1.9 | 03/31/2026 |
| Charles Schwab Investment Management Inc | 3.07 | 952,125 | -1.8 | 03/31/2026 |
| American Century Companies Inc | 3.06 | 948,128 | -0.1 | 03/31/2026 |
Funds
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| Vanguard Total Stock Mkt Idx Inv | 3.18 | 985,990 | +0.0 | 04/30/2026 |
Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.
Insider Transactions
| Date | Person | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 21. Jul 2026 | Veizaga Marvin | Chief Accounting Officer | Other | 16,797 | 13.25 | 222,560 |
| 21. Jul 2026 | Veizaga Marvin | Chief Accounting Officer | Other | 16,797 | 0.00 | – |
| 21. Jul 2026 | Veizaga Marvin | Chief Accounting Officer | Other | 31,480 | 13.25 | 417,110 |
| 21. Jul 2026 | Hawkins Amiee Lin | Chief Operating Officer | Other | 27,897 | 13.25 | 369,635 |
| 21. Jul 2026 | Hawkins Amiee Lin | Chief Operating Officer | Other | 27,897 | 0.00 | – |
| 21. Jul 2026 | Hawkins Amiee Lin | Chief Operating Officer | Other | 43,953 | 13.25 | 582,377 |
| 21. Jul 2026 | Krug Marc S. | Group President, Delivery | Other | 47,120 | 13.25 | 624,340 |
| 21. Jul 2026 | Krug Marc S. | Group President, Delivery | Other | 47,120 | 0.00 | – |
| 21. Jul 2026 | Krug Marc S. | Group President, Delivery | Other | 77,232 | 13.25 | 1,023,324 |
| 21. Jul 2026 | Ball Susan E | General Counsel and Secretary | Other | 72,872 | 13.25 | 965,554 |
| 21. Jul 2026 | Ball Susan E | General Counsel and Secretary | Other | 72,872 | 0.00 | – |
| 21. Jul 2026 | Ball Susan E | General Counsel and Secretary | Other | 241,777 | 13.25 | 3,203,545 |
| 21. Jul 2026 | Burns William J. | Chief Financial Officer | Other | 104,157 | 13.25 | 1,380,080 |
| 21. Jul 2026 | Burns William J. | Chief Financial Officer | Other | 104,157 | 0.00 | – |
| 21. Jul 2026 | Burns William J. | Chief Financial Officer | Other | 336,438 | 13.25 | 4,457,804 |
| 21. Jul 2026 | Clark Kevin Cronin | Chief Executive Officer | Other | 3,961 | 13.25 | 52,483 |
| 21. Jul 2026 | Clark Kevin Cronin | Chief Executive Officer | Other | 247,416 | 13.25 | 3,278,262 |
| 21. Jul 2026 | Clark Kevin Cronin | Chief Executive Officer | Other | 247,416 | 0.00 | – |
| 21. Jul 2026 | Clark Kevin Cronin | Chief Executive Officer | Other | 948,133 | 13.25 | 12,562,762 |
| 21. Jul 2026 | Nevin Janice Elizabeth | Director | Other | 48,616 | 13.25 | 644,162 |
| 21. Jul 2026 | Fitzgerald Gale S | Director | Other | 79,918 | 13.25 | 1,058,914 |
| 21. Jul 2026 | Fitzgerald Gale S | Director | Other | 114,331 | 13.25 | 1,514,886 |
| 21. Jul 2026 | Cash W Larry | Director | Other | 223,312 | 13.25 | 2,958,884 |
| 21. Jul 2026 | Bhamidipati Venkat | Director | Other | 29,759 | 13.25 | 394,307 |
| 21. Jul 2026 | Allen Dwayne | Director | Other | 31,289 | 13.25 | 414,579 |
Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character.
View all insider transactions →Data as of: July 28, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.